Vijay Harypursat

Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial

Yuanyuan Qin, Yihong Zhou, Yanqiu Lu et al. · Chinese Medical Journal · 2020 · 105 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +7

Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol

Yanming Zeng, Xiao-Lei Xu, Xiaoqing He et al. · Chinese Medical Journal · 2020 · 64 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +13

No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study

Yin-Qiu Huang, Shengquan Tang, Xiao-Lei Xu et al. · Frontiers in Pharmacology · 2020 · 55 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

<i>Candida albicans</i> can foster gut dysbiosis and systemic inflammation during HIV infection

Silvère D. Zaongo, Jing Ouyang, Stéphane Isnard et al. · Gut Microbes · 2023 · 44 citations · Full text

Life Sciences, Immunology, Microbiology +17

Pretreatment drug resistance in people living with HIV: A large retrospective cohort study in Chongqing, China

Min Liu, Xiaoqing He, Renni Deng et al. · HIV Medicine · 2022 · 20 citations · Full text

Public Health, Pharmacology, Clinical Epidemiology +16